A systematic overview of systematic reviews evaluating medication adherence interventions

• Published in: American journal of health-system pharmacy 2020-01, Vol.77 (2), p.138-147
• Main Authors: Anderson, Laura J, Nuckols, Teryl K, Coles, Courtney, Le, Michael M, Schnipper, Jeff L, Shane, Rita, Jackevicius, Cynthia, Lee, Joshua, Pevnick, Joshua M
• Format: Article
• Language: English
• Subjects: Humans; Medication Adherence - statistics & numerical data; Practice Research Reports; Systematic Reviews as Topic
• ISSN: 1079-2082; 1535-2900
• DOI: 10.1093/ajhp/zxz284

Abstract Purpose To systematically summarize evidence from multiple systematic reviews (SRs) examining interventions addressing medication nonadherence and to discern differences in effectiveness by intervention, patient, and study characteristics. Summary MEDLINE, the Cochrane Database of Systematic Reviews, and the Database of Abstracts of Reviews of Effects were searched for papers published from January 2004 to February 2017. English-language SRs examining benefits of medication adherence interventions were eligible. Inclusion was limited to adult patients prescribed medication for 1 of the following disease conditions: diabetes and prediabetes, heart conditions, hypertension and prehypertension, stroke, and cognitive impairment. Non–disease-specific SRs that considered medication adherence interventions for older adults, adults with chronic illness, and adults with known medication adherence problems were also included. Two researchers independently screened titles, abstracts, and full-text articles. They then extracted key variables from eligible SRs, reconciling discrepancies via discussion. A MeaSurement Tool to Assess systematic Reviews (AMSTAR) was used to assess SRs; those with scores below 8 were excluded. Conclusions regarding intervention effectiveness were extracted. Grades of Recommendation, Assessment, Development and Evaluation (GRADE) methodology was applied to assess evidence quality. Results Of 390 SRs, 25 met the inclusion criteria and assessed adherence as a primary outcome. Intervention types most consistently found to be effective were dose simplification, patient education, electronic reminders to patients, and reduced patient cost sharing or incentives. Of 50 conclusions drawn by the SRs, the underlying evidence was low or very low quality for 45 SRs. Conclusion Despite an abundance of primary studies and despite only examining high-quality SRs, the vast majority of primary studies supporting SR authors’ conclusions were of low or very low quality. Nonetheless, health system leaders seeking to improve medication adherence should prioritize interventions that have been studied and found to be effective at improving patient adherence, including dose simplification, education, reminders, and financial incentives.